Ebola Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.Anti-spam check. Do not fill this in! ===Treatments=== {{Main|Ebola virus disease treatment research}} [[File:monoclonal antibodies3.jpg|thumb|Researchers looking at slides of cultures of cells that make [[monoclonal antibodies]]. These are grown in a lab and the researchers are analyzing the products to select the most promising.]] {{As of|2015|7}}, no medication has been proven safe and effective for treating Ebola. By the time the [[Ebola virus epidemic in West Africa]] began in 2013, there were at least nine different candidate treatments. Several trials were conducted in late 2014, and early 2015, but some were abandoned due to lack of efficacy or lack of people to study.<ref>{{Cite web |title=Final trial results confirm Ebola vaccine provides high protection against disease |url=https://www.who.int/mediacentre/news/releases/2016/ebola-vaccine-results/en/ |url-status=live |archive-url=https://web.archive.org/web/20170401042946/http://who.int/mediacentre/news/releases/2016/ebola-vaccine-results/en/ |archive-date=1 April 2017 |access-date=29 March 2017 |publisher=[[World Health Organization]] (WHO)}}</ref> {{As of|2019|8}}, two experimental treatments known as [[atoltivimab/maftivimab/odesivimab]] and [[ansuvimab]] were found to be 90% effective.<ref>{{Cite journal |vauthors=Maxmen A |date=12 August 2019 |title=Two Ebola drugs show promise amid ongoing outbreak |journal=Nature |doi=10.1038/d41586-019-02442-6 |issn=0028-0836 |pmid=32778704 |s2cid=201975390}}</ref><ref>{{Cite journal |vauthors=Hoenen T, Groseth A, Feldmann H |date=24 July 2019 |title=Therapeutic strategies to target the Ebola virus life cycle |journal=Nature Reviews. Microbiology |volume=17 |issue=10 |pages=593–606 |doi=10.1038/s41579-019-0233-2 |issn=1740-1526 |pmid=31341272 |doi-access=free}}</ref><ref>{{Cite press release |title=Investigational Monoclonal Antibody to Treat Ebola Is Safe in Adults |date=24 January 2019 |publisher=[[National Institute of Allergy and Infectious Diseases]] (NIAID) |url=https://www.niaid.nih.gov/news-events/investigational-monoclonal-antibody-treat-ebola-safe-adults |access-date=12 August 2019}}</ref> Summary: Please note that all contributions to Christianpedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here. You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see Christianpedia:Copyrights for details). Do not submit copyrighted work without permission! Cancel Editing help (opens in new window) Discuss this page